NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that it has signed an agreement making clinical services provider Best Med Opinion the exclusive distributor of Interpace’s cancer molecular diagnostics in Israel.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.
This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.